AGC Biologics Honored for Innovations in Cell Line Development
October 13, 2022 08:37 ET
|
AGC Biologics
Seattle, Oct. 13, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a 2022...
AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate
September 07, 2022 17:00 ET
|
AGC Biologics
Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
August 20, 2021 13:39 ET
|
AGC Biologics
COPENHAGEN, Aug. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new...
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
August 09, 2021 13:00 ET
|
AGC Biologics
LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
August 05, 2021 12:00 ET
|
AGC Biologics
Seattle, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of...
AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site
August 02, 2021 14:00 ET
|
AGC Biologics
Seattle, Aug. 02, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee...
AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings
July 01, 2021 12:00 ET
|
AGC Biologics
Seattle, July 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement...
Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III
June 23, 2021 08:30 ET
|
AGC Biologics
TEL AVIV, Israel and SEATTLE, Wash., June 23, 2021 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd. (NASDAQ: CMMB), a clinical-stage biotech company focused on the discovery and development of...
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
June 07, 2021 10:06 ET
|
AGC Biologics
Seattle, June 07, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech...
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
May 19, 2021 13:10 ET
|
AGC Biologics
Seattle, May 19, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for...